Correlation Between Corvus Pharmaceuticals and Celldex Therapeutics
Can any of the company-specific risk be diversified away by investing in both Corvus Pharmaceuticals and Celldex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Corvus Pharmaceuticals and Celldex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Corvus Pharmaceuticals and Celldex Therapeutics, you can compare the effects of market volatilities on Corvus Pharmaceuticals and Celldex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Corvus Pharmaceuticals with a short position of Celldex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Corvus Pharmaceuticals and Celldex Therapeutics.
Diversification Opportunities for Corvus Pharmaceuticals and Celldex Therapeutics
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Corvus and Celldex is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Corvus Pharmaceuticals and Celldex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Celldex Therapeutics and Corvus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Corvus Pharmaceuticals are associated (or correlated) with Celldex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Celldex Therapeutics has no effect on the direction of Corvus Pharmaceuticals i.e., Corvus Pharmaceuticals and Celldex Therapeutics go up and down completely randomly.
Pair Corralation between Corvus Pharmaceuticals and Celldex Therapeutics
Given the investment horizon of 90 days Corvus Pharmaceuticals is expected to under-perform the Celldex Therapeutics. In addition to that, Corvus Pharmaceuticals is 1.18 times more volatile than Celldex Therapeutics. It trades about -0.35 of its total potential returns per unit of risk. Celldex Therapeutics is currently generating about -0.16 per unit of volatility. If you would invest 2,454 in Celldex Therapeutics on November 27, 2024 and sell it today you would lose (208.00) from holding Celldex Therapeutics or give up 8.48% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Corvus Pharmaceuticals vs. Celldex Therapeutics
Performance |
| Timeline |
| Corvus Pharmaceuticals |
| Celldex Therapeutics |
Corvus Pharmaceuticals and Celldex Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Corvus Pharmaceuticals and Celldex Therapeutics
The main advantage of trading using opposite Corvus Pharmaceuticals and Celldex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Corvus Pharmaceuticals position performs unexpectedly, Celldex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Celldex Therapeutics will offset losses from the drop in Celldex Therapeutics' long position.| Corvus Pharmaceuticals vs. Mereo BioPharma Group | Corvus Pharmaceuticals vs. Terns Pharmaceuticals | Corvus Pharmaceuticals vs. PDS Biotechnology Corp | Corvus Pharmaceuticals vs. Inozyme Pharma |
| Celldex Therapeutics vs. Ideaya Biosciences | Celldex Therapeutics vs. AnaptysBio | Celldex Therapeutics vs. MeiraGTx Holdings PLC | Celldex Therapeutics vs. Keros Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |